News

Governor Glenn Youngkin Announces Over $3.7 Million in Growth and Opportunity for Virginia Grants

Governor Glenn Youngkin announced today more than $3.7 million in Growth and Opportunity for Virginia (GO Virginia) grant awards for 11 projects designed to empower workforce development, bolster startup ecosystems and promote economic growth in the Commonwealth. These initiatives will play a pivotal role in nurturing skilled talent, fostering entrepreneurial ventures and bridging the gap between job seekers and employment opportunities.

“Today’s announcement underscores our unwavering commitment to stimulating economic growth and expanding opportunities across our Commonwealth,” said Governor Glenn Youngkin. “By investing in talent, bolstering entrepreneurial innovation and cultivating the conditions for startup success, we are actively shaping the future of our workforce and positioning Virginia as a hub for innovation and opportunity.”

The GO Virginia program advances regional economic growth and diversification by enabling cooperative projects that taps into workforce enhancement, cluster expansion, innovative business initiatives and site development.

“The GO Virginia program is at the forefront of driving regional economic growth and diversification by fostering collaborative projects that harness the potential of workforce development and startup ecosystems,” said Secretary of Commerce and Trade Caren Merrick.

In addition to the awarded GO Virginia funding, the 11 awarded projects will leverage an additional $2.5 million in local and non-state funding.

“Congratulations to the regional councils and the awardees. GO Virginia is committed to the economic success of every region of the Commonwealth, and these projects demonstrate how focused strategy and regional collaboration create an ecosystem where industries, communities and individuals can thrive,” said chair of the GO Virginia State Board Nancy Howell Agee.

Since the program’s inception in 2017, GO Virginia has funded 277 projects and awarded approximately $114 million to support regional economic development efforts.

To learn more about the GO Virginia program, visit dhcd.virginia.gov/gova.

A FULL LIST OF THE AWARDED PROJECTS CAN BE FOUND HERE.

Recent News

05/22/2026

BIO Statement on Veto of Prescription Drug Affordability Boards (PDAB) in VirginiaPatrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription Drug Affordability Board (PDAB) and imposed arbitrary price controls in Virginia. The Governor’s action recognized an important point: even well-intentioned healthcare policies must be carefully designed to avoid unintended consequences for patients, providers, employers, and Virginia’s innovation economy. “BIO is proud to represent biotechnology companies developing the next generation of life-changing medicines, including many in the Commonwealth. We believe policymakers play a critically important role in helping advance both patient access to treatments and the continued growth of the life sciences sector. “We look forward to working with the Governor’s Administration, the General Assembly, Virginia Bio and other stakeholders to advance practical, patient-centered policy solutions that improve affordability while preserving access to care and the innovation ecosystem patients depend on.”

Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription

05/21/2026

Virginia Bio Applauds Governor Spanberger’s Veto of SB 271 and HB 483

The Virginia Biotechnology Association (Virginia Bio) today expressed strong support for Governor Abigail Spanberger’s decision to veto Senate Bill 271 and House Bill 483, legislation that would have established a Prescription Drug Affordability Advisory Panel (PDAAP) in the Commonwealth. Virginia Bio and the Virginia Chamber of Commerce sent a joint letter to Governor Spanberger commending

05/21/2026

New Global Clinical Society to Bring Focused Ultrasound Into Mainstream Medicine

The Focused Ultrasound Foundation today announced the launch of the International Focused Ultrasound Society (IFUS), a new organization dedicated to advancing clinical practice and accelerating adoption of focused ultrasound – a revolutionary, noninvasive therapeutic technology. Established as a program of the Focused Ultrasound Foundation, IFUS aggregates and expands the Foundation’s activities related to clinical implementation